InsidersTradesSigma
Total declarations
Companies
▲ Purchases (8 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
8
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-15.2%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Fairbairn Emily, Director. Insider active across 3 companies, notably IN8BIO, INC.. Cumulatively, 20 reports have been logged. Split: 8 buys · 0 sell. Total volume traded: €2m. Activity tracked since 18 November 2021. The latest transaction was filed on 7 July 2026 (C). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Fairbairn Emily
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
1,205,282 shares0Common StockSEC:0001193125-26-298811:0
724,637 shares0Common StockSEC:0001682638-26-000006:0
9,231 shares0Common StockSEC:0001193125-26-138246:0
55,250 shares@ US$1.2510.8% of flowCommon StockSEC:0001193125-26-111335:0
4,470 shares0Common StockSEC:0001193125-26-010719:0
724,637 shares@ US$1.3836.7% of flowCommon StockSEC:0001682638-25-000004:0
12,442 shares0Common StockSEC:0001193125-25-274682:0
31,028 shares0Common StockSEC:0001193125-25-234633:0
27,985 shares0Common StockSEC:0000950170-25-093916:0
65,407 shares0Common StockSEC:0000950170-25-070431:0
4,690,000 sharesCommon StockSEC:0000950170-24-041911:0
Canonical exit: 1 Jul 2024 (T+90)
295,000 shares@ US$0.8545.1% of flowCommon StockSEC:0001209191-23-055331:0
Canonical exit: 12 Feb 2024 (T+90)
4,111,958 shares0Common StockSEC:0001209191-23-044002:0
250,000 shares@ US$1.0044.6% of flowCommon StockSEC:0001209191-23-037292:0
Canonical exit: 11 Sept 2023 (T+90)
178,571 sharesCommon StockSEC:0001209191-23-005533:0
Canonical exit: 27 Apr 2023 (T+90)
789,473 shares@ US$1.90100.0% of flowCommon StockSEC:0001209191-22-046616:0
Canonical exit: 14 Nov 2022 (T+90)
5,000 shares@ US$2.772.2% of flowCommon StockSEC:0001209191-22-022409:0
Canonical exit: 29 Jun 2022 (T+90)
5,000 shares@ US$3.853.1% of flowCommon StockSEC:0001209191-21-066774:0
Canonical exit: 21 Feb 2022 (T+90)
1,000 shares@ US$3.950.6% of flowCommon StockSEC:0001209191-21-065900:0
Canonical exit: 16 Feb 2022 (T+90)
83,124 sharesCommon StockSEC:0001209191-21-049368:0
20 of 20 declarations
About Fairbairn Emily
Emily Fairbairn is Administrateur at Movano Inc., IN8BIO, INC. and Corvex, Inc. The declarant has 20 filings in total, and across the sampled 20 filings covering the period from 2021-08-03 to 2026-07-08, acquisitions total 1973965 EUR and sales 0 EUR, with the modal transaction nature shown as Acquisition.
